Intended for healthcare professionals

  1. Research
  2. Tumour necrosis factor...
  3. Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial
CCBYNC Open access
Research

Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial

BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h1046 (Published 13 March 2015) Cite this as: BMJ 2015;350:h1046

Data supplement

  • Web Extra

    Extra material supplied by the author

    Files in this Data Supplement:

Related articles

EditorialDrug treatments for rheumatoid arthritis: looking backwards to move forwards

See more

Cited by...

  • 2016 update of the EULAR recommendations for the management of rheumatoid arthritis: a utopia beyond patients in low/middle income countries?
  • Response to: '2016 update of the EULAR recommendations for the management of rheumatoid arthritis: no utopia for patients in low/middle-income countries? by Misra et al
  • Impact of intensive treatment and remission on health-related quality of life in early and established rheumatoid arthritis
  • Drug treatments for rheumatoid arthritis: looking backwards to move forwards
Back to top